SS Innovations Bolsters Leadership and Training to Accelerate Global Adoption of Robotic Surgery

SS Innovations International strengthens its executive team and expands surgeon training programs, positioning its SSi Mantra robotic system for wider global adoption and advancing toward U.S. FDA clearance.

LA Metrowire Staff
Healthcare
SS Innovations Bolsters Leadership and Training to Accelerate Global Adoption of Robotic Surgery

SS Innovations International Inc. (NASDAQ: SSII) is intensifying its push to expand the reach of robotic surgery by reinforcing its leadership ranks and investing in surgeon education. The company recently named Sarah M. Romano as chief financial officer, a move that brings more than two decades of finance and capital markets expertise to its executive team. Romano's track record includes raising over $100 million through public and private financings, which will be instrumental as SS Innovations pursues U.S. FDA clearance for its SSi Mantra robotic surgical system and continues its international expansion.

The appointment comes at a pivotal time for the company, which is positioning the SSi Mantra as a cost-effective and user-friendly alternative to established robotic platforms. By pairing advanced technology with a robust training infrastructure, SS Innovations aims to overcome one of the key barriers to adoption: the steep learning curve associated with robotic surgery. The SS International Centre for Robotics Surgery, the company's dedicated training facility, recently graduated its first cardiac robotic training class, comprising 33 healthcare professionals from seven countries. This milestone underscores the company's commitment to ensuring that surgeons worldwide are proficient in using the SSi Mantra system, thereby enhancing patient outcomes and driving broader acceptance.

"The combination of Romano's financial acumen and the expansion of our training programs reflects our dual focus on operational strength and clinical excellence," said a company spokesperson. "We are not only developing innovative technology but also building the ecosystem needed to support its adoption across diverse healthcare settings."

SS Innovations' strategy is particularly notable given the competitive landscape of robotic surgery, which is dominated by a few large players. By offering a system that is both affordable and accessible, the company aims to democratize robotic surgery, making it available to a larger segment of the global population. This approach aligns with its mission to deliver the benefits of robotic surgery to underserved markets, especially in emerging economies where cost is a significant factor.

The company's recent progress includes advancing the SSi Mantra through regulatory pathways and expanding its presence in international markets. The addition of Romano, who has extensive experience in navigating capital markets, is expected to bolster the company's ability to secure the funding needed for these initiatives. Her leadership will be crucial as SS Innovations seeks to scale its operations and bring its robotic system to more patients worldwide.

Industry analysts view the combination of leadership strengthening and training investment as a positive signal for the company's long-term growth. "SS Innovations is taking a comprehensive approach that addresses both the technological and human elements of robotic surgery adoption," noted one analyst. "By investing in surgeon training, they are building a foundation of skilled practitioners who can champion the technology, which is essential for market penetration."

The recent training graduation is just one example of the company's efforts to build a global community of robotic surgeons. The program's international cohort highlights the global demand for surgical robotics training and the company's ability to attract participants from diverse regions. As the company continues to expand its training capabilities, it is likely to see increased adoption of the SSi Mantra system, further solidifying its position in the market.

SS Innovations International is headquartered in India and operates with a vision to make robotic surgery affordable and accessible. Its product portfolio includes the SSi Mantra system and a comprehensive suite of SSi Mudra surgical instruments, which support various procedures, including cardiac surgery. The company plans to leverage its recent leadership and training advancements to accelerate growth and bring its innovative solutions to a broader audience.

For more information about SS Innovations International and its latest developments, visit the company's newsroom at https://ibn.fm/SSII.

Blockchain Registration

QR Code for Blockchain Registration